Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia.
We report a patient with acute myeloid leukemia and Blastoschizomyces capitatus sepsis who developed multiple abscesses when neutrophils recovered. The patient did not respond to antifungal therapy and her clinical condition showed an improvement only after rhGM-CSF was added to the treatment.
Pagano
L
L
Istituto di Semeiotica Medica, Università Cattolica del Sacro Cuore, Rome, Italy.
Morace
G
G
Ortu-La Barbera
E
E
Sanguinetti
M
M
Leone
G
G
D000208:Acute Disease; D000368:Aged; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D009181:Mycoses / Q000188:drug therapy* / Q000276:immunology; D009503:Neutropenia / Q000188:drug therapy; D009504:Neutrophils / Q000276:immunology; D009894:Opportunistic Infections / Q000188:drug therapy*; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor